To Evaluate the Safety and Tolerability of SYHX2001 in Patients With Advanced or Metastatic Solid Tumors
Clinical trial NCT05407909 · UNKNOWN
Trial details
- NCT number
- NCT05407909
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-27
- Primary completion
- 2026-01-06
- Enrollment
- 176
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.